Literature DB >> 17984821

Immune reconstitution inflammatory syndrome associated with progressive multifocal leukoencephalopathy in a perinatally acquired human immunodeficiency virus-infected young adult.

Tong Wei Ch'ng1, Arry Dieudonne.   

Abstract

Perinatally infected children represent a large proportion of the youth living with human immunodeficiency virusinfection/acquired immunodeficiency syndrome (HIV/AIDS). Because of nonadherence to treatment, an increasing number of perinatally acquired HIV-infected adolescents and young adults are showing virologic failure and immune suppression. We report a case of progressive multifocal leukoencephalopathy secondary to immune reconstitution inflammatory syndrome in a perinatally HIV-infected young adult, occurred shortly after the revision of an antiretroviral regimen. The patient showed marked improvement with the combination of corticosteroid and antiretroviral treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984821     DOI: 10.1097/INF.0b013e31812e62fa

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  3 in total

Review 1.  Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review.

Authors:  Hayden Schwenk; Lynn Ramirez-Avila; Shu-Hsien Sheu; Christian Wuthrich; Jeff Waugh; Adam Was; Umberto Degirolami; Sandra Burchett; Igor J Koralnik; Asim Ahmed
Journal:  Pediatr Infect Dis J       Date:  2014-04       Impact factor: 2.129

Review 2.  Immune reconstitution inflammatory syndrome after initiating highly active antiretroviral therapy in HIV-infected children.

Authors:  Tracy Kilborn; Marco Zampoli
Journal:  Pediatr Radiol       Date:  2009-03-10

Review 3.  Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature Review.

Authors:  Anna Fournier; Guillaume Martin-Blondel; Emmanuèle Lechapt-Zalcman; Julia Dina; Apolline Kazemi; Renaud Verdon; Emmanuel Mortier; Arnaud de La Blanchardière
Journal:  Front Immunol       Date:  2017-05-23       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.